3 results match your criteria: "European Commission -DG Joint Research Centre (JRC)[Affiliation]"
Toxicol Appl Pharmacol
September 2018
European Commission -DG Joint Research Centre (JRC), Ispra, Italy. Electronic address:
This consensus statement voices the agreement of scientific stakeholders from regulatory agencies, academia and industry that a new framework needs adopting for assessment of chemicals with the potential to disrupt brain development. An increased prevalence of neurodevelopmental disorders in children has been observed that cannot solely be explained by genetics and recently pre- and postnatal exposure to environmental chemicals has been suspected as a causal factor. There is only very limited information on neurodevelopmental toxicity, leaving thousands of chemicals, that are present in the environment, with high uncertainty concerning their developmental neurotoxicity (DNT) potential.
View Article and Find Full Text PDFALTEX
August 2018
Organisation for Economic Co-operation and Development (OECD), Paris, France.
Crit Rev Toxicol
October 2010
Nanobiosciences Unit, European Commission-DG Joint Research Centre (JRC), Institute for Health and Consumer Protection (IHCP), Ispra, Italy.
Carbon nanotubes (CNTs) possess many unique electronic and mechanical properties and are thus interesting for numerous novel industrial and biomedical applications. As the level of production and use of these materials increases, so too does the potential risk to human health. This study aims to investigate the feasibility and challenges associated with conducting a human health risk assessment for carbon nanotubes based on the open literature, utilising an approach similar to that of a classical regulatory risk assessment.
View Article and Find Full Text PDF